Identifying research priorities for the study of drug-related progressive multifocal leukoencephalopathy (PML)

View source ↗

Summary

EMA identifies research priorities to study drug-related progressive multifocal leukoencephalopathy (PML) to better understand risks and management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multifocal Leukoencephalopathy